193 related articles for article (PubMed ID: 15265780)
1. Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?
Kino T; Chrousos GP
Ann N Y Acad Sci; 2004 Jun; 1024():153-67. PubMed ID: 15265780
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related lipodystrophy/insulin resistance syndrome.
Kino T; Mirani M; Alesci S; Chrousos GP
Horm Metab Res; 2003 Mar; 35(3):129-36. PubMed ID: 12734771
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
Forget J; Yao XJ; Mercier J; Cohen EA
J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
5. Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.
Kino T; Pavlakis GN
DNA Cell Biol; 2004 Apr; 23(4):193-205. PubMed ID: 15142377
[TBL] [Abstract][Full Text] [Related]
6. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression.
Mouland AJ; Coady M; Yao XJ; Cohen EA
Virology; 2002 Jan; 292(2):321-30. PubMed ID: 11878934
[TBL] [Abstract][Full Text] [Related]
8. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr.
Mansky LM; Preveral S; Le Rouzic E; Bernard LC; Selig L; Depienne C; Benarous R; Benichou S
Virology; 2001 Mar; 282(1):176-85. PubMed ID: 11259200
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity.
Subbramanian RA; Yao XJ; Dilhuydy H; Rougeau N; Bergeron D; Robitaille Y; Cohen EA
J Mol Biol; 1998 Apr; 278(1):13-30. PubMed ID: 9571031
[TBL] [Abstract][Full Text] [Related]
10. Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect.
Kewalramani VN; Park CS; Gallombardo PA; Emerman M
Virology; 1996 Apr; 218(2):326-34. PubMed ID: 8610459
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients.
Kino T; De Martino MU; Charmandari E; Ichijo T; Outas T; Chrousos GP
Diabetes; 2005 Jan; 54(1):23-31. PubMed ID: 15616007
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity.
Fakruddin JM; Laurence J
Arch Virol; 2005 Jan; 150(1):67-78. PubMed ID: 15449141
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
[TBL] [Abstract][Full Text] [Related]
14. Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.
Janoo A; Morrow PW; Tung HY
J Cell Biochem; 2005 Mar; 94(4):816-25. PubMed ID: 15578586
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
[TBL] [Abstract][Full Text] [Related]
16. Modulation of HIV-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of HIV-1 pathogenesis.
Hapgood JP; Tomasicchio M
Arch Virol; 2010 Jul; 155(7):1009-19. PubMed ID: 20446002
[TBL] [Abstract][Full Text] [Related]
17. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr.
Gragerov A; Kino T; Ilyina-Gragerova G; Chrousos GP; Pavlakis GN
Virology; 1998 Jun; 245(2):323-30. PubMed ID: 9636371
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest.
Sherman MP; de Noronha CM; Pearce D; Greene WC
J Virol; 2000 Sep; 74(17):8159-65. PubMed ID: 10933727
[TBL] [Abstract][Full Text] [Related]
19. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages.
Nitahara-Kasahara Y; Kamata M; Yamamoto T; Zhang X; Miyamoto Y; Muneta K; Iijima S; Yoneda Y; Tsunetsugu-Yokota Y; Aida Y
J Virol; 2007 May; 81(10):5284-93. PubMed ID: 17344301
[TBL] [Abstract][Full Text] [Related]
20. [Studies on HIV/AIDS using the fission yeast Schizosaccharomyces pombe].
Masuda M
Rinsho Byori; 2005 Oct; 53(10):950-6. PubMed ID: 16296344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
